<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id><journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id><journal-title-group><journal-title>BMC Research Notes</journal-title></journal-title-group><issn pub-type="epub">1756-0500</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6119312</article-id><article-id pub-id-type="publisher-id">3735</article-id><article-id pub-id-type="doi">10.1186/s13104-018-3735-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Note</subject></subj-group></article-categories><title-group><article-title>Characterization of <italic>bla</italic><sub>CTX-M</sub> sequences of Indian origin and thirteen uropathogenic <italic>Escherichia coli</italic> isolates resistant to multiple antibiotics</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Siddaramappa</surname><given-names>Shivakumara</given-names></name><address><email>shivakumar@ibab.ac.in</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pullela</surname><given-names>Karthik</given-names></name><address><email>karthik5670@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Thimmappa</surname><given-names>Bhagya</given-names></name><address><email>bhagyathimmappa@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Devkota</surname><given-names>Ranjan</given-names></name><address><email>ranjanprashantii9@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bajaj</surname><given-names>Rani</given-names></name><address><email>brani@ibab.ac.in</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Manivannan</surname><given-names>Bhavani</given-names></name><address><email>mbhavani@sssihl.edu.in</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mahalingam</surname><given-names>Niranjana</given-names></name><address><email>mniranjana000@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8022-8168</contrib-id><name><surname>Pradeep</surname><given-names>Bulagonda Eswarappa</given-names></name><address><email>bepradeep@sssihl.edu.in</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0500 991X</institution-id><institution-id institution-id-type="GRID">grid.418831.7</institution-id><institution>Institute of Bioinformatics and Applied Biotechnology, Biotech Park, Electronic City, </institution></institution-wrap>Bengaluru, Karnataka India </aff><aff id="Aff2"><label>2</label>Sri Sathya Sai Institute of Higher Learning, Vidyagiri, Prasanthi Nilayam, Andhra Pradesh India </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000418047691</institution-id><institution-id institution-id-type="GRID">grid.416282.b</institution-id><institution>Sri Sathya Sai Institute of Higher Medical Sciences, </institution></institution-wrap>Prasanthigram, Andhra Pradesh India </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>11</volume><elocation-id>630</elocation-id><history><date date-type="received"><day>12</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>25</day><month>8</month><year>2018</year></date></history><permissions><copyright-statement>&#169; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objectives</title><p id="Par1">ESBL-producing isolates of the <italic>Enterobacteriaceae</italic> occur throughout the world. The objectives of this study were to characterize uropathogenic <italic>Escherichia coli</italic> isolated at a tertiary care hospital in southern India, and shed light on <italic>bla</italic><sub>CTX-M</sub> sequences of Indian origin.</p></sec><sec><title>Results</title><p id="Par2">A cohort of 13 urinary isolates of <italic>E. coli</italic> (obtained from patients at the Sri Sathya Sai Institute of Higher Medical Sciences, Prasanthigram, Andhra Pradesh, India) were characterized and found to be resistant to multiple antibiotics, including extended-spectrum cephalosporins. All 13 isolates contained <italic>bla</italic><sub>CTX-M-15</sub>, and many of them transferred this genotype to at least one laboratory strain of <italic>E. coli</italic> after conjugation. Analyses of <italic>bla</italic><sub>CTX-M-15</sub> sequences (n&#8201;=&#8201;141) of Indian origin showed that&#8201;&gt;&#8201;85% of them were obtained from bacteria not associated with the urinary tract, and that <italic>E. coli</italic> isolates account for majority of all <italic>bla</italic><sub>CTX-M-15</sub>-carrying bacteria reported from India. Other types of <italic>bla</italic><sub>CTX-M</sub> appear to be rare in India, since only six such sequences were reported as of July 2015. The results indicate that &#8216;selection pressure&#8217; exerted by extended-spectrum cephalosporins may have stabilized the <italic>bla</italic><sub>CTX-M-15</sub> genotype among <italic>E. coli</italic> in India. The rarity of other <italic>bla</italic><sub>CTX-M</sub> suggests that they lack the survival advantage that <italic>bla</italic><sub>CTX-M-15</sub> may have.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s13104-018-3735-5) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>Enterobacteriaceae</italic></kwd><kwd><italic>Escherichia coli</italic></kwd><kwd>Resistance</kwd><kwd>ESBL</kwd><kwd><italic>bla</italic><sub>CTX-M-15</sub></kwd><kwd>HGT</kwd><kwd>India</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001843</institution-id><institution>Science and Engineering Research Board</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par7">Diseases caused by extraintestinal pathogenic <italic>Escherichia coli</italic> (ExPEC) strains among humans are as common and debilitating as those caused by intestinal pathogenic <italic>E. coli</italic> (InPEC) strains [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Uropathogenic <italic>E. coli</italic> (UPEC) strains are the most common type of ExPEC that cause urinary tract infections (UTIs) and are a global burden [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Most of the UPEC isolates are reported to produce extended spectrum &#946;-lactamases (ESBLs) that limit the choice of therapy [<xref ref-type="bibr" rid="CR5">5</xref>]. These ESBLs hydrolyze extended-spectrum cephalosporins and the genes encoding them are frequently plasmid and/or mobile element-borne [<xref ref-type="bibr" rid="CR6">6</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>]. Worldwide, CTX-M is the predominant ESBL type and most of the enzymes within this family mediate resistance to cefotaxime and ceftriaxone [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. In 2001, a derivative of CTX-M-3 was reported from India that &#8220;conferred a higher level of resistance to ceftazidime&#8221; and was designated CTX-M-15 [<xref ref-type="bibr" rid="CR11">11</xref>]. In the first systematic survey of <italic>E. coli</italic> resistant to third-generation cephalosporins in India, it was shown that 73% of the isolates carry <italic>bla</italic><sub>CTX-M-15</sub> and that many of these genes were associated with IS<italic>26</italic> [<xref ref-type="bibr" rid="CR12">12</xref>]. The <italic>bla</italic><sub>CTX-M-15</sub> genotype appears to be common among <italic>E. coli</italic> sequence type 131, which is a multidrug-resistant clonal group associated with urinary tract and bloodstream infections [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par8">Previous studies focused on understanding the features of 16 UPEC ST131 isolates from India revealed that many of them contain large conjugative plasmids encoding the CTX-M-15 &#946;-lactamase [<xref ref-type="bibr" rid="CR5">5</xref>]. Although the sequences of <italic>bla</italic><sub>CTX-M-15</sub> from these 16 ST131 isolates are not available, their diversity was reported to be low [<xref ref-type="bibr" rid="CR5">5</xref>]. It has also been reported that UTI-associated <italic>E. coli</italic> isolates from HIV patients in India were more likely to contain <italic>bla</italic><sub>CTX-M-15</sub> than those from non-HIV patients, and that their ESBL phenotype correlated with the presence of <italic>bla</italic><sub>CTX-M-15</sub> [<xref ref-type="bibr" rid="CR16">16</xref>]. Although several other reports contain details of ESBL-positive <italic>E. coli</italic> isolates from India [<xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref>], systematic analyses of <italic>bla</italic><sub>CTX-M-15</sub> are lacking. The objectives of this study were to characterize ESBL-producing <italic>E. coli</italic> isolated at the Sri Sathya Sai Institute of Higher Medical Sciences, Prasanthigram, Andhra Pradesh, India, and to compare the <italic>bla</italic><sub>CTX-M</sub> sequences among these and other bacteria of Indian origin.</p></sec><sec id="Sec2"><title>Main text</title><sec id="Sec3"><title>Materials and methods</title><sec id="Sec4"><title>Bacterial isolates, conjugation, and sequence analysis</title><p id="Par9">Bacterial isolates (n&#8201;=&#8201;70) were obtained from the clinical microbiology section of the Sri Sathya Sai Institute of Higher Medical Sciences, Prasanthigram, Andhra Pradesh, India. These isolates represented pure cultures derived from non-HIV patients. The isolates were identified using VITEK 2 systems version 06.01 (bioM&#233;rieux). Antibiotic susceptibility testing of the isolates was performed using VITEK-2 AST-N280 cards (bioM&#233;rieux) and the results were interpreted based on the clinical and laboratory standards institute guidelines (CLSI M100-S24; 2014). Bacterial chromosomal DNA, obtained after heat lysis of pure cultures [<xref ref-type="bibr" rid="CR20">20</xref>], served as the template for amplification of gene segments. Isolates were screened for <italic>bla</italic><sub>CTX-M</sub>, <italic>bla</italic><sub>SHV</sub>, and <italic>bla</italic><sub>TEM</sub> genes using PCR as described previously [<xref ref-type="bibr" rid="CR21">21</xref>&#8211;<xref ref-type="bibr" rid="CR24">24</xref>]. Primer sequences and thermocycling protocol are provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>. Products amplified by PCR were gel purified, cloned, and sequenced.</p><p id="Par10">Horizontal transferability of genes/elements encoding antibiotic resistance was tested using three different <italic>E. coli</italic> recipient strains in conjugation experiments. These include strain B (a component of the HiPer<sup>&#174;</sup> bacterial conjugation teaching kit supplied by Hi Media Laboratories Pvt Ltd., Mumbai, India), strain XL1-Blue (supplied by the erstwhile Stratagene, La Jolla, CA), and strain BL-21 CodonPlus (also supplied by Stratagene), which are resistant to streptomycin, tetracycline, and chloramphenicol, respectively. Conjugation protocol is provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p><p id="Par11">Clustal omega (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/msa/clustalo/">http://www.ebi.ac.uk/Tools/msa/clustalo/</ext-link>) was used to obtain an initial alignment of the <italic>bla</italic><sub>CTX-M</sub> sequences. This alignment was used as a guide to manually trim the sequences when they were of different lengths. Progressive alignment of DNA sequences was performed using ClustalW with default parameters. Phylogeny was reconstructed using the maximum likelihood method (with 1000 bootstrap replicates) and the Tamura-Nei substitution/scoring matrix in MEGA 6.0.</p></sec></sec><sec id="Sec5"><title>Results</title><sec id="Sec6"><title>Antibiotic resistance</title><p id="Par12">Thirteen apparently disparate isolates were selected for further study based on them containing plasmids of various sizes (data not shown). The isolates were confirmed as <italic>E. coli</italic> using the amplification and sequencing of their 16S rDNA genes. The sources of these 13 isolates and the clinical complaints/diagnosis of the patients are listed in Additional file <xref rid="MOESM2" ref-type="media">2</xref>. Antibiotic sensitivity testing in the clinical laboratory using VITEK-2 showed that all 13 isolates were resistant to extended spectrum &#946;-lactam antibiotics such as cefazolin, ceftriaxone, and/or cefepime, indicating that they were capable of producing ESBLs (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). However, most of these isolates were sensitive to ertapenem, imipenem, and/or meropenem, indicating that they were carabapenemase negative (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). All 13 isolates consistently tested positive for <italic>bla</italic><sub>CTX-M</sub>, but negative for <italic>bla</italic><sub>SHV</sub> and <italic>bla</italic><sub>TEM</sub>, in PCR experiments.<table-wrap id="Tab1"><label>Table&#160;1</label><caption><p>Antibiotic sensitivity testing of urinary isolates of <italic>E. coli</italic> in the clinical laboratory using VITEK-2 AST-N280 cards</p></caption><table-wrap-foot><p><italic>MIC</italic> minimum inhibitory concentration (&#181;g/ml), <italic>INT</italic> interpretation, <italic>R</italic> resistant, <italic>S</italic> sensitive, <italic>I</italic> intermediate, <italic>NT</italic> not tested</p></table-wrap-foot></table-wrap>
</p><p id="Par13">The 13 isolates shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref> were further screened in the research laboratory for their sensitivity to six antibiotics using LB agar plates. Laboratory strains of <italic>E. coli</italic> (B, DH5&#945;, XL1-Blue, and BL-21 CodonPlus) were used as controls in these tests. All 13 isolates were resistant to ampicillin and nalidixic acid (100&#160;&#181;g/ml each; data not shown). Except isolate Q57, all others were also resistant to kanamycin (50&#160;&#181;g/ml; data not shown). Data is shown in Table&#160;<xref rid="Tab2" ref-type="table">2</xref> for four isolates (Q41A, Q66, Q72, and Q76A) that were sensitive to streptomycin (100&#160;&#181;g/ml) and tetracycline (60&#160;&#181;g/ml), for three isolates (P8, Q42, and Q76B) that were sensitive to streptomycin but resistant to tetracycline, and for one isolate (Q57) that was sensitive to tetracycline but resistant to streptomycin. Except isolates P20, P28A, and P45, all others were sensitive to chloramphenicol (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). These results suggest that the 13 isolates are sufficiently disparate and non-clonal.<table-wrap id="Tab2"><label>Table&#160;2</label><caption><p>Antibiotic sensitivity testing of urinary isolates of <italic>E. coli</italic> in the research laboratory and the results of conjugation experiments</p></caption></table-wrap>
</p></sec><sec id="Sec7"><title>Horizontal transfer of bla<sub>CTX-M</sub></title><p id="Par14">Conjugation was performed based on the antibiotic sensitivity of the 10 donor/clinical isolates using appropriate recipient strains. Isolates P8, Q41A, Q42, Q66, Q72, Q76A, or Q76B were conjugated with <italic>E. coli</italic> strain B as the recipient and produced transconjugants that were resistant to ampicillin and streptomycin (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Furthermore, transconjugants obtained using isolates P8, Q42, or Q76B were resistant to tetracycline, and transconjugants obtained using isolates P8, Q42, Q66, Q72, Q76A, and&#160;Q76B were resistant to nalidixic acid. These results indicate that in some clinical isolates, different resistance determinants were co-located and/or co-transferable. Such mobilizable elements encoding resistance to extended spectrum &#946;-lactam antibiotics and several other antibacterial drugs have been reported among ST131 isolates from India [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par15">Isolates Q41A, Q57, Q66, Q72, and&#160;Q76A were conjugated with <italic>E. coli</italic> strain XL1-Blue as the recipient and produced transconjugants that were resistant to ampicillin and tetracycline (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Interestingly, strain XL1-Blue transconjugants obtained using isolates Q57, Q72, or Q76A readily transferred ampicillin resistance to strain B after secondary conjugation (data not shown). However, none of the strain B transconjugants that were sensitive to tetracycline could transfer ampicillin resistance to strain XL1-Blue after secondary conjugation. This indicates that some strain XL1-Blue transconjugants, unlike those of strain B, possess the traits to serve as donors, and that conjugative elements borne by some strains (such as Q41A and Q66) may require host-derived factors for their efficient mobilization.</p><p id="Par16"><italic>Escherichia coli</italic> strain BL-21 CodonPlus is generally used for protein expression and contains a ColE1-compatible pACYC-based plasmid (~&#8201;3.5&#160;kb) that confers chloramphenicol resistance. The suitability of this strain as a recipient in conjugation experiments has not been reported. Isolates P8, P12, P19, Q41A, Q42, Q57, Q66, Q72, Q76A, or Q76B were conjugated with strain BL-21 CodonPlus as the recipient and produced transconjugants that were resistant to ampicillin and chloramphenicol (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). The presence of <italic>bla</italic><sub>CTX-M</sub> in ampicillin-resistant strain B, XL-1 Blue, or BL-21 CodonPlus transconjugants was confirmed using PCR (data not shown).</p></sec><sec id="Sec8"><title>Epidemiology of bla<sub>CTX-M</sub> in India</title><p id="Par17">From each of the 13 isolates,&#8201;~&#8201;541&#160;bp fragment of the <italic>bla</italic><sub>CTX-M</sub> gene was amplified by PCR, cloned, and sequenced. Sequence comparison by blastn indicated that all 13 isolates carried a <italic>bla</italic><sub>CTX-M-15</sub> gene (GenBank accession numbers are shown in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). For further comparison, a total of 133 <italic>bla</italic><sub>CTX-M</sub> sequences deposited in GenBank from various parts of India from February 2008 to July 2015 (plus the first <italic>bla</italic><sub>CTX-M-15</sub> sequence with the accession number AAL02127 submitted in July 2001) were obtained (Additional file <xref rid="MOESM3" ref-type="media">3</xref>). Since the sequences varied in length, they were trimmed to obtain a 191&#160;bp internal fragment after multiple sequence alignment. A maximum likelihood phylogenetic tree (with 1000 bootstrap replicates) constructed using 147 <italic>bla</italic><sub>CTX-M</sub> sequences showed that 96% of them (141/147, including 13 from the isolates characterized in this study) cluster together (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Among the 141 sequences that were compared in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>, the 191&#160;bp internal fragment was almost identical, indicating the genetic homogeneity of <italic>bla</italic><sub>CTX-M-15</sub>. Not surprisingly, 51% (72/141) of the sequences were from <italic>E. coli</italic> isolates, and 26% (37/141) were from <italic>Klebsiella pneumoniae</italic> isolates. Interestingly, two sequences were from <italic>Pseudomonas aeruginosa</italic> isolates causing ocular infections (Additional file <xref rid="MOESM3" ref-type="media">3</xref>). Furthermore, only 13% of the sequences (19/141) were from <italic>E. coli</italic> cultured using urine samples. Other types of <italic>bla</italic><sub>CTX-M</sub> appear to be rare in India, since only one sequence for each of <italic>bla</italic><sub>CTX-M-1</sub>, <italic>bla</italic><sub>CTX-M-8</sub>, <italic>bla</italic><sub>CTX-M-9</sub>, and <italic>bla</italic><sub>CTX-M-14</sub> and two sequences of <italic>bla</italic><sub>CTX-M-27</sub> were found in the GenBank database. These <italic>bla</italic><sub>CTX-M</sub> sequences were also from <italic>E. coli</italic> and <italic>K. pneumoniae</italic> (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref> and Additional file <xref rid="MOESM3" ref-type="media">3</xref>).<fig id="Fig1"><label>Fig.&#160;1</label><caption><p>Phylogenetic tree based on 147 <italic>bla</italic><sub>CTX-M</sub> sequences (191&#160;bp). The unrooted tree was constructed using the maximum likelihood method in MEGA 6.0. Bootstrap values of 1000 replicates are indicated as numbers out of 100 at the nodes. Scale bar shows the number of nucleotide substitutions per site. &#8216;SSSIHL <italic>E. coli</italic>&#8217; refer to the <italic>bla</italic><sub>CTX-M-15</sub> sequences from the 13 isolates characterized in this study whose accession numbers are given in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>. The accession numbers of 134 <italic>bla</italic><sub>CTX-M</sub> sequences (128 of <italic>bla</italic><sub>CTX-M-15</sub>, two of <italic>bla</italic><sub>CTX-M-27</sub>, one each of <italic>bla</italic><sub>CTX-M-1</sub>, <italic>bla</italic><sub>CTX-M-8</sub>, <italic>bla</italic><sub>CTX-M-9</sub>, and <italic>bla</italic><sub>CTX-M-14</sub>) are shown in the figure (and in Additional file <xref rid="MOESM3" ref-type="media">3</xref>). Colors used for representing various bacterial genera/species are explained within the figure. The first <italic>bla</italic><sub>CTX-M-15</sub> sequence with the accession number AAL02127 submitted in July 2001 is highlighted in orange. A representative 191&#160;bp <italic>bla</italic><sub>CTX-M-15</sub> sequence (from isolate Q76A) is also shown within the figure</p></caption><graphic xlink:href="13104_2018_3735_Fig1_HTML" id="MO1"/></fig>
</p></sec></sec><sec id="Sec9"><title>Discussion</title><p id="Par18">In a previous study assessing the drug resistance of 16 ESBL-producing <italic>E. coli</italic> isolates, it was reported that 84% were resistant to ciprofloxacin [<xref ref-type="bibr" rid="CR5">5</xref>]. Furthermore, resistance to extended spectrum &#946;-lactam antibiotics and fluoroquinolones among UTI-associated <italic>E. coli</italic> isolates from HIV patients was reported to be significantly higher than those from non-HIV patients [<xref ref-type="bibr" rid="CR16">16</xref>]. Co-resistance to ciprofloxacin and at least one extended spectrum &#946;-lactam antibiotic has also been reported among <italic>E. coli</italic> isolates from pregnant women [<xref ref-type="bibr" rid="CR17">17</xref>]. In the current study, eleven isolates (85%) were found to be resistant to ciprofloxacin. These results suggest that fluoroquinolones are not a good choice in the Indian scenario for treating ESBL-producing <italic>E. coli</italic>. Based on previous reports [<xref ref-type="bibr" rid="CR5">5</xref>] and current work, it appears that at least 70% of UTI-associated ESBL-producing <italic>E. coli</italic> isolates could be sensitive to chloramphenicol. This sensitivity may be due to infrequent use of chloramphenicol in humans, and provides a choice to clinicians to prescribe the drug for life-threatening infections caused by <italic>E. coli</italic>. The results of the conjugation experiments indicate that the <italic>bla</italic><sub>CTX-M-15</sub> gene was borne on a mobile genetic element in each donor strain. It was obvious from this study that members of the <italic>Enterobacteriaceae</italic> are the majority among all potentially ESBL-producing bacteria of clinical relevance in India. It appears that the genetic and epidemiological features of CTX-M &#946;-lactamases have not changed much since the first systematic survey reported in 2006 [<xref ref-type="bibr" rid="CR12">12</xref>]. Sequence analyses indicated that <italic>E. coli</italic> isolates account for at least 50% of all <italic>bla</italic><sub>CTX-M-15</sub> carrying bacteria, and that other types of <italic>bla</italic><sub>CTX-M</sub> are rare in India. Therefore, there is likely a &#8220;strong selection pressure&#8221; for the maintenance and dispersal of the <italic>bla</italic><sub>CTX-M-15</sub> genotype among pathogenic <italic>E. coli</italic> in India. In view of this, diagnostic laboratories should routinely test clinical isolates of <italic>E. coli</italic> for <italic>bla</italic><sub>CTX-M-15</sub>, and hospitals should develop and implement an antibiotic stewardship program to reverse the trend.</p></sec></sec><sec id="Sec10"><title>Limitations</title><p id="Par19">This work relied on few&#160;ESBL-positive UPEC isolates from a single hospital. Studies using many isolates from different hospitals could provide broader insights into ESBL-positive UPEC in India. For conjugation experiments, three different recipient strains of <italic>E. coli</italic> were used. A single recipient <italic>E. coli</italic> strain could help in better assessment of horizontal gene transfer. This study used <italic>bla</italic><sub>CTX-M-15</sub> sequences available in GenBank regardless of the origins of the host strains. Future studies could look into the distribution of <italic>bla</italic><sub>CTX-M-15</sub> among clinical and non-clinical strains.</p></sec><sec sec-type="supplementary-material"><title>Additional files</title><sec id="Sec11"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13104_2018_3735_MOESM1_ESM.pdf"><caption><p><bold>Additional file 1.</bold> Primer sequences and thermocycling protocol.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13104_2018_3735_MOESM2_ESM.pdf"><caption><p><bold>Additional file 2.</bold> Clinical isolates used in this study and their sources.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13104_2018_3735_MOESM3_ESM.pdf"><caption><p><bold>Additional file 3.</bold> Details of <italic>bla</italic><sub>CTX-M</sub> sequences deposited in GenBank from various parts of India that were used in this study.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term><italic>bla</italic></term><def><p id="Par3">&#946;-lactamase</p></def></def-item><def-item><term>CTX</term><def><p id="Par4">cefotaxime</p></def></def-item><def-item><term>ESBL</term><def><p id="Par5">extended spectrum &#946;-lactamase</p></def></def-item><def-item><term>HGT</term><def><p id="Par6">horizontal gene transfer</p></def></def-item></def-list></glossary><ack><title>Authors&#8217; contributions</title><p>SS: contributed to designing the study, performed sequence analyses, and wrote the manuscript; BT and RB: performed plasmid profiling, PCR, and conjugation experiments; KP, RD, BM, and NM: isolated the bacteria and identified them using VITEK 2; BEP: designed the study, interpreted the results, and contributed to drafting the manuscript. All authors read and approved the final manuscript.</p><sec id="FPar1"><title>Acknowledgements</title><p id="Par20">The authors wish to thank Ms. Vandana Viswanathan, Ms. Neha Gupta, and Mr. Kalmesh Vyaparagi of IBAB for providing technical assistance. The authors also wish to thank Ms. Anushree Narjala for help with phylogenetic analysis.</p></sec><sec id="FPar2"><title>Competing interests</title><p id="Par21">The authors declare that they have no competing interests.</p></sec><sec id="FPar3"><title>Availability of data and materials</title><p id="Par22">DNA sequences generated as part of this work have been deposited in GenBank (Accession Numbers: KU987444, KT956436, KY568704, KT956438, KY568702, KY568703, KT956439, KU987443, KX009505, KT956440, KT956441, KT956442, and KX009504). <italic>E. coli</italic> isolates and protocols used in the study are available from the corresponding author.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par23">Since patient identities were not sought for the study, consent for publication is not applicable.</p></sec><sec id="FPar5"><title>Ethics approval and consent to participate</title><p id="Par24">The Institutional Ethics Committee of the Sri Sathya Sai Institute of Higher Learning (ECR/616/Inst/Ap/2014/RR-17) reviewed and approved the project (SSSIHL/IEC/PSN/BS/2014/03). Since this was a retrospective study, informed patient consent is not applicable.</p></sec><sec id="FPar6"><title>Funding</title><p id="Par25">Research at IBAB is continuously supported by the Department of Innovation and Technology of the Government of Karnataka. This work was primarily supported by funds provided through the FAST TRACK SCHEME FOR YOUNG SCIENTISTS (06/2012 to 05/2015) of the Science and Engineering Research Board of the Department of Science and Technology, Government of India to B.E.P. Research infrastructure at the Department of Biosciences, SSSIHL, Prasanthi Nilayam was set up with funds from the Government of India through UGC-SAP (DRS), DST-FIST, and DBT-BIF. Research infrastructure at IBAB was set up with funds from DST-FIST.</p></sec><sec id="FPar7"><title>Publisher&#8217;s Note</title><p id="Par26">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriel</surname><given-names>DG</given-names></name><name><surname>Rosini</surname><given-names>R</given-names></name><name><surname>Seib</surname><given-names>KL</given-names></name><name><surname>Serino</surname><given-names>L</given-names></name><name><surname>Pizza</surname><given-names>M</given-names></name><name><surname>Rappuoli</surname><given-names>R</given-names></name></person-group><article-title><italic>Escherichia coli</italic>: great diversity around a common core</article-title><source>MBio</source><year>2012</year><volume>3</volume><fpage>e00118</fpage><pub-id pub-id-type="doi">10.1128/mBio.00118-12</pub-id><?supplied-pmid 22669628?><pub-id pub-id-type="pmid">22669628</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poolman</surname><given-names>JT</given-names></name><name><surname>Wacker</surname><given-names>M</given-names></name></person-group><article-title>Extra intestinal pathogenic <italic>Escherichia coli</italic>, a common human pathogen: challenges for vaccine development and progress in the field</article-title><source>J Infect Dis</source><year>2016</year><volume>213</volume><fpage>6</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiv429</pub-id><?supplied-pmid 26333944?><pub-id pub-id-type="pmid">26333944</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimitrov</surname><given-names>TS</given-names></name><name><surname>Udo</surname><given-names>EE</given-names></name><name><surname>Emara</surname><given-names>M</given-names></name><name><surname>Awni</surname><given-names>F</given-names></name><name><surname>Passadilla</surname><given-names>R</given-names></name></person-group><article-title>Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait Hospital</article-title><source>Med Princ Pract.</source><year>2004</year><volume>13</volume><fpage>334</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1159/000080470</pub-id><?supplied-pmid 15467308?><pub-id pub-id-type="pmid">15467308</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Totsika</surname><given-names>M</given-names></name><name><surname>Moriel</surname><given-names>DG</given-names></name><name><surname>Idris</surname><given-names>A</given-names></name><name><surname>Rogers</surname><given-names>BA</given-names></name><name><surname>Wurpel</surname><given-names>DJ</given-names></name><name><surname>Phan</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Uropathogenic <italic>Escherichia coli</italic> mediated urinary tract infection</article-title><source>Curr Drug Targets</source><year>2012</year><volume>13</volume><fpage>1386</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.2174/138945012803530206</pub-id><?supplied-pmid 22664092?><pub-id pub-id-type="pmid">22664092</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>A</given-names></name><name><surname>Ewers</surname><given-names>C</given-names></name><name><surname>Nandanwar</surname><given-names>N</given-names></name><name><surname>Guenther</surname><given-names>S</given-names></name><name><surname>Jadhav</surname><given-names>S</given-names></name><name><surname>Wieler</surname><given-names>LH</given-names></name><etal/></person-group><article-title>Multiresistant uropathogenic <italic>Escherichia coli</italic> from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-&#946;-lactamase-producing lineage</article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><fpage>6358</fpage><lpage>6365</lpage><pub-id pub-id-type="doi">10.1128/AAC.01099-12</pub-id><?supplied-pmid 23045357?><pub-id pub-id-type="pmid">23045357</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>DL</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name></person-group><article-title>Extended-spectrum &#946;-lactamases: a clinical update</article-title><source>Clin Microbiol Rev</source><year>2005</year><volume>18</volume><fpage>657</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1128/CMR.18.4.657-686.2005</pub-id><?supplied-pmid 16223952?><pub-id pub-id-type="pmid">16223952</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Zarouni</surname><given-names>M</given-names></name><name><surname>Senok</surname><given-names>A</given-names></name><name><surname>Rashid</surname><given-names>F</given-names></name><name><surname>Al-Jesmi</surname><given-names>SM</given-names></name><name><surname>Panigrahi</surname><given-names>D</given-names></name></person-group><article-title>Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing <italic>Enterobacteriaceae</italic> in the United Arab Emirates</article-title><source>Med Princ Pract.</source><year>2008</year><volume>17</volume><fpage>32</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1159/000109587</pub-id><?supplied-pmid 18059098?><pub-id pub-id-type="pmid">18059098</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Sweih</surname><given-names>N</given-names></name><name><surname>Jamal</surname><given-names>W</given-names></name><name><surname>Rotimi</surname><given-names>VO</given-names></name></person-group><article-title>Spectrum and antibiotic resistance of uropathogens isolated from hospital and community patients with urinary tract infections in two large hospitals in Kuwait</article-title><source>Med Princ Pract.</source><year>2005</year><volume>14</volume><fpage>401</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1159/000088113</pub-id><?supplied-pmid 16220013?><pub-id pub-id-type="pmid">16220013</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzouvelekis</surname><given-names>LS</given-names></name><name><surname>Tzelepi</surname><given-names>E</given-names></name><name><surname>Tassios</surname><given-names>PT</given-names></name><name><surname>Legakis</surname><given-names>NJ</given-names></name></person-group><article-title>CTX-M-type &#946;-lactamases: an emerging group of extended-spectrum enzymes</article-title><source>Int J Antimicrob Agents</source><year>2000</year><volume>14</volume><fpage>137</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/S0924-8579(99)00165-X</pub-id><?supplied-pmid 10720804?><pub-id pub-id-type="pmid">10720804</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cant&#243;n</surname><given-names>R</given-names></name><name><surname>Coque</surname><given-names>TM</given-names></name></person-group><article-title>The CTX-M &#946;-lactamase pandemic</article-title><source>Curr Opin Microbiol</source><year>2006</year><volume>9</volume><fpage>466</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2006.08.011</pub-id><?supplied-pmid 16942899?><pub-id pub-id-type="pmid">16942899</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karim</surname><given-names>A</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Nagarajan</surname><given-names>S</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name></person-group><article-title>Plasmid-mediated extended-spectrum &#946;-lactamase (CTX-M-3 like) from India and gene association with insertion sequence IS<italic>Ecp1</italic></article-title><source>FEMS Microbiol Lett</source><year>2001</year><volume>201</volume><fpage>237</fpage><lpage>241</lpage><?supplied-pmid 11470367?><pub-id pub-id-type="pmid">11470367</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ensor</surname><given-names>VM</given-names></name><name><surname>Shahid</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>JT</given-names></name><name><surname>Hawkey</surname><given-names>PM</given-names></name></person-group><article-title>Occurrence, prevalence and genetic environment of CTX-M &#946;-lactamases in <italic>Enterobacteriaceae</italic> from Indian hospitals</article-title><source>J Antimicrob Chemother</source><year>2006</year><volume>58</volume><fpage>1260</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1093/jac/dkl422</pub-id><?supplied-pmid 17071956?><pub-id pub-id-type="pmid">17071956</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JR</given-names></name><name><surname>Johnston</surname><given-names>B</given-names></name><name><surname>Clabots</surname><given-names>C</given-names></name><name><surname>Kuskowski</surname><given-names>MA</given-names></name><name><surname>Castanheira</surname><given-names>M</given-names></name></person-group><article-title><italic>Escherichia coli</italic> sequence type ST131 as the major cause of serious multidrug-resistant <italic>E. coli</italic> infections in the United States</article-title><source>Clin Infect Dis</source><year>2010</year><volume>51</volume><fpage>286</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1086/653932</pub-id><?supplied-pmid 20572763?><pub-id pub-id-type="pmid">20572763</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Partridge</surname><given-names>SR</given-names></name><name><surname>Zong</surname><given-names>Z</given-names></name><name><surname>Iredell</surname><given-names>JR</given-names></name></person-group><article-title>Recombination in IS<italic>26</italic> and Tn<italic>2</italic> in the evolution of multiresistance regions carrying <italic>bla</italic><sub>CTX-M-15</sub> on conjugative IncF plasmids from <italic>Escherichia coli</italic></article-title><source>Antimicrob Agents Chemother</source><year>2011</year><volume>55</volume><fpage>4971</fpage><lpage>4978</lpage><pub-id pub-id-type="doi">10.1128/AAC.00025-11</pub-id><?supplied-pmid 21859935?><pub-id pub-id-type="pmid">21859935</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petty</surname><given-names>NK</given-names></name><name><surname>Ben Zakour</surname><given-names>NL</given-names></name><name><surname>Stanton-Cook</surname><given-names>M</given-names></name><name><surname>Skippington</surname><given-names>E</given-names></name><name><surname>Totsika</surname><given-names>M</given-names></name><name><surname>Forde</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Global dissemination of a multidrug resistant <italic>Escherichia coli</italic> clone</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>5694</fpage><lpage>5699</lpage><pub-id pub-id-type="doi">10.1073/pnas.1322678111</pub-id><?supplied-pmid 24706808?><pub-id pub-id-type="pmid">24706808</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmavathy</surname><given-names>K</given-names></name><name><surname>Padma</surname><given-names>K</given-names></name><name><surname>Rajasekaran</surname><given-names>S</given-names></name></person-group><article-title>Multidrug resistant CTX-M-producing <italic>Escherichia coli</italic>: a growing threat among HIV patients in India</article-title><source>J Pathog.</source><year>2016</year><volume>2016</volume><fpage>4152704</fpage><pub-id pub-id-type="doi">10.1155/2016/4152704</pub-id><?supplied-pmid 27123344?><pub-id pub-id-type="pmid">27123344</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>A</given-names></name><name><surname>Chandran</surname><given-names>SP</given-names></name><name><surname>Mahadik</surname><given-names>K</given-names></name><name><surname>Macaden</surname><given-names>R</given-names></name><name><surname>Lundborg</surname><given-names>CS</given-names></name></person-group><article-title>Frequency and factors associated with carriage of multi-drug resistant commensal <italic>Escherichia coli</italic> among women attending antenatal clinics in central India</article-title><source>BMC Infect Dis</source><year>2013</year><volume>13</volume><fpage>199</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-13-199</pub-id><?supplied-pmid 23638834?><pub-id pub-id-type="pmid">23638834</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhara</surname><given-names>L</given-names></name><name><surname>Tripathi</surname><given-names>A</given-names></name></person-group><article-title>Genetic and structural insights into plasmid-mediated extended-spectrum &#946;-lactamase activity of CTX-M and SHV variants among pathogenic <italic>Enterobacteriaceae</italic> infecting Indian patients</article-title><source>Int J Antimicrob Agents</source><year>2014</year><volume>43</volume><fpage>518</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2014.03.002</pub-id><?supplied-pmid 24794736?><pub-id pub-id-type="pmid">24794736</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul-Satyaseela</surname><given-names>M</given-names></name><name><surname>Murali</surname><given-names>S</given-names></name><name><surname>Thirunavukkarasu</surname><given-names>B</given-names></name><name><surname>Naraharirao</surname><given-names>MH</given-names></name><name><surname>Jambulingam</surname><given-names>M</given-names></name></person-group><article-title>Characterization of antibiotic resistance profiles of ocular <italic>Enterobacteriaceae</italic> isolates</article-title><source>Eur J Microbiol Immunol.</source><year>2016</year><volume>6</volume><fpage>40</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1556/1886.2015.00047</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>S</given-names></name><name><surname>Agarwal</surname><given-names>RK</given-names></name><name><surname>Bist</surname><given-names>B</given-names></name></person-group><article-title>Comparison of ELISA and PCR vis-&#224;-vis cultural methods for detecting <italic>Aeromonas</italic> spp. in foods of animal origin</article-title><source>Int J Food Microbiol</source><year>2006</year><volume>106</volume><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2005.06.019</pub-id><?supplied-pmid 16216375?><pub-id pub-id-type="pmid">16216375</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weill</surname><given-names>FX</given-names></name><name><surname>Demartin</surname><given-names>M</given-names></name><name><surname>Tand&#233;</surname><given-names>D</given-names></name><name><surname>Espi&#233;</surname><given-names>E</given-names></name><name><surname>Rakotoarivony</surname><given-names>I</given-names></name><name><surname>Grimont</surname><given-names>PA</given-names></name></person-group><article-title>SHV-12-like extended-spectrum-&#946;-lactamase-producing strains of <italic>Salmonella enterica</italic> serotypes Babelsberg and Enteritidis isolated in France among infants adopted from Mali</article-title><source>J Clin Microbiol</source><year>2004</year><volume>42</volume><fpage>2432</fpage><lpage>2437</lpage><pub-id pub-id-type="doi">10.1128/JCM.42.6.2432-2437.2004</pub-id><?supplied-pmid 15184415?><pub-id pub-id-type="pmid">15184415</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitout</surname><given-names>JD</given-names></name><name><surname>Hamilton</surname><given-names>N</given-names></name><name><surname>Church</surname><given-names>DL</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name></person-group><article-title>Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type &#946;-lactamases in <italic>Enterobacteriaceae</italic></article-title><source>Clin Microbiol Infect</source><year>2007</year><volume>13</volume><fpage>291</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2006.01645.x</pub-id><?supplied-pmid 17391384?><pub-id pub-id-type="pmid">17391384</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfaresi</surname><given-names>MS</given-names></name><name><surname>Elkoush</surname><given-names>AA</given-names></name><name><surname>Alshehhi</surname><given-names>HM</given-names></name><name><surname>Abdulsalam</surname><given-names>AI</given-names></name></person-group><article-title>Molecular characterization and epidemiology of extended-spectrum beta-lactamase-producing <italic>Escherichia coli</italic> and <italic>Klebsiella pneumoniae</italic> isolates in the United Arab Emirates</article-title><source>Med Princ Pract.</source><year>2011</year><volume>20</volume><fpage>177</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1159/000319912</pub-id><?supplied-pmid 21252576?><pub-id pub-id-type="pmid">21252576</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyedjavadi</surname><given-names>SS</given-names></name><name><surname>Goudarzi</surname><given-names>M</given-names></name><name><surname>Sabzehali</surname><given-names>F</given-names></name></person-group><article-title>Relation between <italic>bla</italic><sub>TEM</sub>, <italic>bla</italic><sub>SHV</sub> and <italic>bla</italic><sub>CTX-M</sub> genes and acute urinary tract infections</article-title><source>J Acute Dis.</source><year>2016</year><volume>5</volume><fpage>71</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.joad.2015.07.007</pub-id></element-citation></ref></ref-list></back></article>